Evidence guide · UAE

Male fertility supplements: sperm rankings versus the trials that counted babies

A new network meta-analysis ranks zinc and omega-3 high for sperm measures, but three large trials, with more than 3,700 men, found no gain in pregnancies or births. Safety limits and the rules in the UK, US, UAE and South Africa.

Review type: research summary. This page summarises published research and product labels, cited below.

Supplements for male fertility usually combine zinc, folic acid, selenium, vitamins C and E, L-carnitine, coenzyme Q10 or lycopene, and are sold on the promise of better sperm. On 17 November 2026 the Asian Journal of Andrology published a network meta-analysis of 56 randomised trials that ranks these ingredients by their effect on semen measures. Zinc and omega-3 ranked relatively high across all six measures.

Short answer: some supplements may shift sperm counts or motility on a lab report, but three large placebo-controlled trials that counted pregnancies or births found no benefit for couples. They covered more than 3,700 men, and one found a lower pregnancy rate in one time window on the supplement. A Cochrane review found a possible benefit only in small studies at high risk of bias, and England's NICE guideline says not to offer supplements or antioxidants to improve sperm DNA integrity. If you are trying for a baby, a fertility assessment for both partners matters more than any capsule.

Grades used here: Strong (consistent results from several good-quality human trials), Moderate (good trials, but few or with mixed results), Limited (small or low-quality human studies, or good studies in other groups of people), Insufficient (too little human research to judge) and Evidence of harm.

What the new ranking found

Shen and colleagues searched four databases up to 16 January 2026 for randomised trials of dietary supplements in men with infertility and included 56 studies. A network meta-analysis compares many treatments at once, including pairs never compared head to head, and ranks them. For semen volume, the top five were lycopene, Nigella sativa (black seed) oil, zinc, ubiquinol and myo-inositol. For sperm concentration, the top five were omega-3, zinc, myo-inositol, lycopene and curcumin nanomicelle. For progressive motility, zinc, alpha-lipoic acid, myo-inositol, vitamin E and L-acetyl-carnitine came top; for normal sperm shape, N-acetylcysteine, zinc, omega-3, black seed oil and curcumin nanomicelle.

The abstract ranks semen measures only. It reports no ranking for pregnancy or live birth, which is what couples want. A higher rank is the authors' estimate of which ingredient came out ahead on that measure. It does not show how large the gain was, whether that difference was statistically clear, or that the gain leads to a baby. The authors say the effect varies between semen measures and that individual patient characteristics should be considered when choosing.

Semen measures: Limited

Many small trials report changes in sperm count, motility or shape with one ingredient or another, and the new ranking pools them. The large placebo-controlled trials did not confirm these changes. In the FAZST trial, most semen measures did not differ between folic acid plus zinc and placebo after six months, and DNA fragmentation was slightly higher on the supplement (29.7% v 27.2%). In the MOXI trial, the antioxidant did not improve sperm shape, motility or DNA fragmentation after three months. The change in sperm concentration did differ, with a median fall on the antioxidant and a median rise on placebo. In the SUMMER trial, semen measures and DNA fragmentation showed no significant difference from placebo.

Pregnancy and live birth: no benefit in three large trials

FAZST, run at four US fertility centres, randomised 2,370 men in couples planning infertility treatment to 5 mg folic acid and 30 mg zinc daily, or placebo, for six months. Live birth rates were 34% on the supplement and 35% on placebo (risk difference -0.9%, 95% CI -4.7% to 2.8%). Abdominal discomfort or pain (6% v 3%), nausea (4% v 2%) and vomiting (3% v 1%) were more common on the supplement. The authors concluded that the results do not support folic acid and zinc for male partners in infertility treatment.

MOXI, run at nine US fertility centres, randomly assigned 171 men with at least one abnormal semen or sperm DNA result to an antioxidant or placebo. The paper's formula contained 500 mg vitamin C, 400 mg vitamin E, 0.2 mg selenium, 1,000 mg L-carnitine, 20 mg zinc, 1,000 µg folic acid, 10 mg lycopene and 2,000 IU vitamin D daily. The trial registry lists vitamin E as 400 IU, not 400 mg. Cumulative live birth at six months did not differ: 15% on the antioxidant and 24% on placebo. The authors note the trial was limited by its size.

SUMMER, run in 21 Dutch hospitals and clinics, analysed 1,171 men seeking fertility care who were randomly assigned to a daily antioxidant tablet (Impryl, containing 200 mg betaine, 200 mg L-cystine, 16 mg niacin, 10 mg zinc, 1.4 mg vitamin B6, 1.4 mg vitamin B2, 2.5 µg vitamin B12 and 400 µg folic acid) or placebo for six months, alongside standard care. Ongoing pregnancy within six months was 33.8% on the supplement and 37.5% on placebo, not a significant difference. Between months 4 and 6, the window the investigators set to allow for a 72-day sperm production cycle, the ongoing pregnancy rate was significantly lower on the supplement (15.5% v 21.5%). The investigators do not support its use. The trial was supported by an unrestricted grant from Goodlife Pharma, which developed and marketed Impryl and also supplied the study tablets.

What the Cochrane review says

A 2022 Cochrane review of 90 studies in 10,303 men attending fertility clinics, with searches up to February 2021, found very low-certainty evidence that antioxidants may increase live birth (odds ratio 1.43, 12 trials, 1,283 men). When studies at high risk of bias were removed, the live-birth benefit was no longer seen (8 trials, 827 men). Antioxidants may lead to more mild stomach discomfort (low-certainty evidence). The authors say couples should be told the evidence is inconclusive, because of poor reporting of randomisation, missing pregnancy and birth outcomes, high dropout and small samples. The searches pre-date the SUMMER results.

Safety: more is not better

Vitamin E ranks highly for motility in the new analysis. The MOXI paper reports 400 mg of vitamin E in the formula, while the trial registry lists 400 IU, so the two figures are not one dose. In the SELECT trial, with 34,887 men in the main analysis aged 55 or over (50 or over for Black men), 400 IU a day of vitamin E increased prostate cancer risk by 17% compared with placebo (hazard ratio 1.17), an absolute increase of 1.6 cases per 1,000 person-years. The NHS says high doses of zinc reduce the copper the body can absorb, which can lead to anaemia and weakening of the bones, and advises not taking more than 25 mg of zinc supplements a day unless a doctor advises it. FAZST used 30 mg. For selenium, the NHS says 350 µg a day or less from supplements is unlikely to cause harm, and that too much causes selenosis, which in its mildest form can lead to loss of hair and nails. Stacking several fertility products can push zinc or selenium above the NHS figures above. The SELECT vitamin E result is from older men and is not a label limit for men trying to conceive.

What the guidelines say

NICE's fertility guideline for England, updated on 31 March 2026, says not to offer supplements, antioxidants or medical treatments to improve sperm DNA integrity (fragmentation). It also says people concerned about their fertility should be told that the effectiveness of complementary therapies for fertility problems has not been properly evaluated and that more research is needed before they can be recommended.

Our view

  • Rankings of semen measures are not evidence that a supplement helps a couple have a baby. Three large trials that counted pregnancies and births, with more than 3,700 men between them, found no benefit.
  • If you have been trying for a year without success, or sooner if you already know of a fertility problem, see a doctor. In England, the NHS says women aged 36 and over should see a GP sooner. Both partners should be assessed, including a semen analysis.
  • If you still want to try a supplement, choose one product, check the zinc and selenium on the label against the NHS figures above, and do not stack formulas.
  • The NHS lists smoking, drinking too much alcohol and obesity among the factors that can reduce fertility. Dealing with those is a better first step than a capsule.

UAE rules

None of the trials above were run in the UAE, and fertility formulas sold here vary in what they contain. If you have been trying for a year without success, both partners should see a doctor or a fertility clinic. Before starting a fertility supplement, ask a pharmacist at Bin Sina, Supercare or Medicina to check the zinc, selenium and vitamin E amounts against anything else you take.

FAQ

Do fertility supplements for men work?

Some small trials report better semen results, but three large placebo-controlled trials (FAZST, MOXI and SUMMER) found no improvement in live birth or ongoing pregnancy. A Cochrane review rated the evidence for a live-birth benefit as very low certainty.

Which supplement is best for sperm?

A 2026 network meta-analysis of 56 trials ranked zinc and omega-3 relatively high across six semen measures. Rankings do not show the size of any gain, and they do not show more pregnancies or births.

How long do sperm take to change?

The SUMMER investigators allowed for a sperm production cycle of 72 days and looked separately at months 4 to 6. In that window, pregnancy rates were lower on the supplement than on placebo.

Is zinc safe to take for fertility?

The NHS advises not taking more than 25 mg of zinc supplements a day unless a doctor advises it, because high doses reduce copper absorption. In the FAZST trial, 30 mg of zinc with 5 mg of folic acid caused more stomach upset than placebo and did not improve live birth.

Sources

These are the documents this page relies on.

  1. Shen XY, Lu LJ, Che BW, et al. Efficacy of dietary supplements in improving sperm parameters in men with infertility: a network meta-analysis. Asian J Androl. Published online 17 November 2026. doi:10.4103/aja202658Asian Journal of Andrology (PubMed 43042579)
  2. Schisterman EF, Sjaarda LA, Clemons T, et al. Effect of folic acid and zinc supplementation in men on semen quality and live birth among couples undergoing infertility treatment: a randomized clinical trial. JAMA. 2020;323(1):35-48JAMA (PubMed 31910279)
  3. Steiner AZ, Hansen KR, Barnhart KT, et al. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertil Steril. 2020;113(3):552-560Fertility and Sterility (PubMed 32111479)
  4. Males, Antioxidants, and Infertility (MOXI): study record NCT02421887ClinicalTrials.gov
  5. de Ligny WR, de Bruin JP, Smits RM, et al. Antioxidant treatment and the chance to conceive in men seeking fertility care: the SUMMER randomized clinical trial. JAMA Netw Open. 2025;8(9):e2532405JAMA Network Open (PubMed 40996763)
  6. de Ligny W, Smits RM, Mackenzie-Proctor R, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022;5:CD007411Cochrane Database of Systematic Reviews (PubMed 35506389)
  7. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556JAMA (PubMed 21990298)
  8. Fertility problems: assessment and treatment (NG257, published 31 March 2026): management of male factor fertility problems, recommendation 1.24.6National Institute for Health and Care Excellence
  9. Fertility problems: assessment and treatment (NG257): advice about factors that can affect fertility, recommendation 1.14.1National Institute for Health and Care Excellence
  10. Vitamins and minerals: others (selenium and zinc)NHS
  11. InfertilityNHS